Comments
Loading...
Plus Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:PSTV | Benzinga
Plus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 14
EPS Estimate
$-0.340
Quarterly Revenue Estimate
$1.11M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Plus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PSTV | Plus Therapeutics | -$0.75 | -$0.34 | — | — | $1.68M | $1.11M | — | — | 05/14/2025 | Get Alert |
| PSTV | Plus Therapeutics | -$0.70 | -$0.50 | -$0.67 | -34.00% | $1.31M | $1.01M | $1.41M | 39.80% | 03/27/2025 | Get Alert |
| PSTV | Plus Therapeutics | -$1.00 | -$0.56 | -$0.37 | 33.93% | $1.24M | $1.14M | $1.46M | 27.72% | 11/14/2024 | Get Alert |
| PSTV | Plus Therapeutics | -$0.59 | -$0.53 | -$0.71 | -33.96% | $1.85M | $1.67M | $1.28M | -23.41% | 08/14/2024 | Get Alert |
| PSTV | Plus Therapeutics | -$2.07 | -$1.09 | -$0.75 | 31.19% | $506.00K | $1.69M | $1.68M | -0.77% | 05/15/2024 | Get Alert |
| PSTV | Plus Therapeutics | -$2.40 | -$1.07 | -$0.70 | 34.58% | $151.00K | $1.06M | $1.31M | 23.87% | 03/05/2024 | Get Alert |
| PSTV | Plus Therapeutics | -$2.85 | -$1.12 | -$1.00 | 10.71% | $73.00K | $1.29M | $1.24M | -3.88% | 10/31/2023 | Get Alert |
| PSTV | Plus Therapeutics | -$3.60 | -$1.91 | -$0.59 | 69.11% | $0.00 | $790.00K | $1.85M | 134.68% | 08/14/2023 | Get Alert |
| PSTV | Plus Therapeutics | -$2.85 | -$1.95 | -$2.10 | -7.69% | $0.00 | $740.00K | $506.00K | -31.62% | 04/20/2023 | Get Alert |
| PSTV | Plus Therapeutics | -$4.05 | -$1.80 | -$2.40 | -33.33% | $0.00 | $1.27M | $151.00K | -88.11% | 02/23/2023 | Get Alert |
| PSTV | Plus Therapeutics | -$4.20 | -$3.30 | -$2.85 | 13.64% | $0.00 | — | $73.00K | — | 10/20/2022 | Get Alert |
| PSTV | Plus Therapeutics | -$3.75 | -$3.60 | -$3.60 | 0.00% | $0.00 | — | $0.00 | — | 07/21/2022 | Get Alert |
| PSTV | Plus Therapeutics | -$4.95 | -$2.70 | -$2.85 | -5.56% | $0.00 | — | $0.00 | — | 04/21/2022 | Get Alert |
| PSTV | Plus Therapeutics | -$11.10 | -$4.05 | -$4.05 | 0.00% | $0.00 | — | $0.00 | — | 02/24/2022 | Get Alert |
| PSTV | Plus Therapeutics | -$5.85 | -$3.15 | -$4.20 | -33.33% | $0.00 | $1.96M | $0.00 | -100.00% | 10/21/2021 | Get Alert |
| PSTV | Plus Therapeutics | -$6.75 | -$3.60 | -$3.75 | -4.17% | $185.00K | — | $0.00 | — | 07/22/2021 | Get Alert |
| PSTV | Plus Therapeutics | -$4.20 | -$5.10 | -$4.95 | 2.94% | $118.00K | — | $0.00 | — | 04/22/2021 | Get Alert |
| PSTV | Plus Therapeutics | $9.90 | -$5.85 | -$11.10 | -89.74% | $1.19M | — | $0.00 | — | 02/22/2021 | Get Alert |
| PSTV | Plus Therapeutics | -$0.45 | -$9.75 | -$5.85 | 40.00% | $4.77M | — | $0.00 | — | 10/22/2020 | Get Alert |
| PSTV | Plus Therapeutics | -$76.80 | -$11.25 | -$6.75 | 40.00% | $302.00K | — | $185.00K | — | 08/10/2020 | Get Alert |
| PSTV | Plus Therapeutics | -$0.18 | -$11.25 | -$4.20 | 62.67% | $703.00K | — | $118.00K | — | 05/14/2020 | Get Alert |
Plus Therapeutics (PSTV) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $-0.67 | $-0.50 | -34.0 % |
| Q3 | 2024-11-14 | $-0.37 | $-0.56 | 33.9 % |
| Q2 | 2024-08-14 | $-0.71 | $-0.53 | -34.0 % |
| Q1 | 2024-05-15 | $-0.75 | $-1.09 | 31.2 % |
Plus Therapeutics (PSTV) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-27 | $1.41M | $1.01M | 39.8 % |
| Q3 | 2024-11-14 | $1.46M | $1.14M | 27.7 % |
| Q2 | 2024-08-14 | $1.28M | $1.67M | -23.4 % |
| Q1 | 2024-05-15 | $1.68M | $1.69M | -0.77 % |
FAQ
When is Plus Therapeutics (NASDAQ:PSTV) reporting earnings?
Plus Therapeutics (PSTV) is scheduled to report earnings on May 14, 2025. The last reported earnings were for reported on March 27, 2025 for Q4.
What were the latest earnings per share (EPS) for Plus Therapeutics (NASDAQ:PSTV)?
The Actual EPS was $-0.67, which missed the estimate of $-0.50.
What were Plus Therapeutics’s (NASDAQ:PSTV) revenues?
The Actual Revenue was $1.4M, which beat the estimate of $1M.
Browse earnings estimates, EPS, and revenue on all stocks.
